Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Amarin Corporation plc is a biotechnology business based in the US. Amarin Corporation shares (AMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Amarin Corporation employs 1,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$4.45|
|52-week range||$3.36 - $9.25|
|50-day moving average||$4.49|
|200-day moving average||$5.61|
|Wall St. target price||$10.13|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.00|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-07-25)||N/A|
|1 month (2021-07-02)||1.37%|
|3 months (2021-05-05)||-5.32%|
|6 months (2021-02-01)||N/A|
|1 year (2020-08-01)||N/A|
|2 years (2019-08-01)||N/A|
|3 years (2018-08-01)||N/A|
|5 years (2016-08-01)||N/A|
Valuing Amarin Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amarin Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amarin Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2140x. In other words, Amarin Corporation shares trade at around 2140x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Amarin Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.1 million.
The EBITDA is a measure of a Amarin Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$601.2 million|
|Operating margin TTM||0.51%|
|Gross profit TTM||$482.6 million|
|Return on assets TTM||0.2%|
|Return on equity TTM||0.15%|
|Market capitalisation||$1.7 billion|
TTM: trailing 12 months
There are currently 20.0 million Amarin Corporation shares held short by investors – that's known as Amarin Corporation's "short interest". This figure is 14.9% down from 23.5 million last month.
There are a few different ways that this level of interest in shorting Amarin Corporation shares can be evaluated.
Amarin Corporation's "short interest ratio" (SIR) is the quantity of Amarin Corporation shares currently shorted divided by the average quantity of Amarin Corporation shares traded daily (recently around 3.8 million). Amarin Corporation's SIR currently stands at 5.26. In other words for every 100,000 Amarin Corporation shares traded daily on the market, roughly 5260 shares are currently held short.
However Amarin Corporation's short interest can also be evaluated against the total number of Amarin Corporation shares, or, against the total number of tradable Amarin Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amarin Corporation's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Amarin Corporation shares in existence, roughly 50 shares are currently held short) or 0.0558% of the tradable shares (for every 100,000 tradable Amarin Corporation shares, roughly 56 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Amarin Corporation.
Find out more about how you can short Amarin Corporation stock.
We're not expecting Amarin Corporation to pay a dividend over the next 12 months.
Amarin Corporation's shares were split on a 1:10 basis on 17 January 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amarin Corporation shares which in turn could have impacted Amarin Corporation's share price.
Over the last 12 months, Amarin Corporation's shares have ranged in value from as little as $3.36 up to $9.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin Corporation's is 2.2421. This would suggest that Amarin Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co. , Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999.
Everything we know about the Chobani IPO, plus information on how to buy in.
Everything we know about the Stronghold Digital Mining IPO, plus information on how to buy in.
Everything we know about the ROX Financial LP IPO, plus information on how to buy in.
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
Everything we know about the RenovoRx IPO, plus information on how to buy in.
Everything we know about the Draganfly IPO, plus information on how to buy in.
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
Everything we know about the Marpai IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.